group | age | gender | lesion location | stroke onset | comorbidities |
---|---|---|---|---|---|
RAGT + VR | 68 | M | r FP | 12 | 3 |
63 | M | l PO | 7 | 2,3 | |
57 | M | r TP | 5 | 1,4 | |
62 | F | l PO | 7 | 1 | |
60 | M | r FP | 6 | 1,2 | |
59 | M | r P | 10 | 2,3 | |
66 | M | l F | 6 | 3 | |
56 | F | r FP | 10 | 1,2 | |
58 | M | l PO | 8 | 1,2,4 | |
55 | F | r FP | 8 | 1,4 | |
65 | F | l PO | 8 | 1,3 | |
55 | F | r TP | 7 | 1,4 | |
mean ± SD | 60 ± 4 | 7 M;5F | 8 ± 2 | ||
RAGT-VR | 58 | M | r P | 8 | 1,3,5 |
72 | F | l F | 11 | 2,3 | |
59 | M | l F | 5 | 1,2 | |
54 | M | r P | 5 | 2 | |
55 | F | r P | 10 | 1 | |
73 | M | r TP | 8 | 3,5 | |
63 | F | l TP | 8 | 2,2 | |
64 | M | r P | 11 | 2,3 | |
64 | F | l F | 6 | 3 | |
65 | M | r P | 8 | 1,3,5 | |
65 | F | l F | 8 | 2,3 | |
66 | M | l F | 8 | 3 | |
mean ± SD | 63 ± 6 | 7 M;5F | 8 ± 2 |